UBS plans return optimization notes due 2017 with cap tied to stocks

By Susanna Moon

Chicago, Feb. 2 – UBS AG, London Branch plans to price 0% return optimization securities due April 18, 2017 linked to a basket of 10 equally weighted common stocks, according to an FWP filing with the Securities and Exchange Commission.

The underlying companies are AbbVie Inc., Aetna Inc., Boeing Co., General Dynamics Corp., Gilead Sciences, Inc., Intel Corp., Lennar Corp., Pfizer Inc., Prologis, Inc. and Walt Disney Co.

The payout at maturity will be par of $10 plus triple any index gain, up to a maximum return of 16.2% to 19.2%. The exact cap will be set at pricing.

Investors will be exposed to any losses.

UBS Financial Services Inc. and UBS Investment Bank are the agents.

The notes will price on Feb. 12 and settle on Feb. 18.

The Cusip number is 90275L557.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.